Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...
Alix Harvey, a 35-year-old marine biologist from Plymouth, welcomed the move to increase access to the weight-loss drug. She ...
However, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, warned that weight loss jabs “are not a ...
Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...
Mounjaro is a prescription drug, and like most drugs it can cause side effects, such as constipation. Over-the-counter laxatives and lifestyle changes may help relieve constipation. Digestive side ...
The U.K. will soon offer Eli Lilly's Mounjaro for people with obesity — but only to a small share of those medically eligible ...
The NHS spending watchdog has recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for those with a body mass index (BMI) of more than 35 and at least one weight-related illness.
Ozempic (semaglutide) and Mounjaro (tirzepatide) are prescription drugs used to manage type 2 diabetes. They can also help with weight loss. Both drugs are injected once per week. Ozempic and ...
The NHS spending watchdog has recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for those with a body mass index (BMI) of more than 35 and at least one weight-related illness.